Tag: immune checkpoint inhibitor trials

Designing and Conducting Immunotherapy Trials in Oncology

August 15, 2025

Designing and Conducting Immunotherapy Trials in Oncology Step-by-Step Guide to Planning and Conducting Immunotherapy Trials in Oncology Introduction to Immunotherapy Trials Immunotherapy trials represent one of the fastest-growing areas in oncology clinical research. These trials aim to harness and modulate the patient’s immune system to recognize and destroy cancer cells. Therapies include immune checkpoint inhibitors…

Immunotherapy Studies, Oncology Clinical Trials

Early vs Late Phase Trials in Immuno-Oncology

August 3, 2025

digi

Early vs Late Phase Trials in Immuno-Oncology Comparing Early and Late Phase Trials in Immuno-Oncology Introduction to Immuno-Oncology Clinical Development Immuno-oncology (I-O) has transformed cancer treatment, introducing therapies that harness the immune system to recognize and destroy tumor cells. The clinical development of I-O agents follows the traditional phase-based pathway—Phase I (early), Phase II, Phase…

Oncology Clinical Trials, Phase-Specific Oncology Trials